Skip to main content

UM School of Medicine's Dr. Karen Kotloff Receives 2019 Alumni Achievement Award from Temple University

May 06, 2019 | Joanne Morrison

Karen Kotloff, MD

Karen Kotloff, MD, Professor of Pediatrics at the University of Maryland School of Medicine (UMSOM), has received the 2019 Alumni Achievement Award from the Lewis Katz School of Medicine at Temple University.

This award, which was presented on May 4, recognizes alumni whose contributions to medicine have had a lasting impact. Dr. Kotloff, who is Head of UMSOM’s Division of Pediatric Infectious Diseases and Tropical Medicine and an Associate Director in UMSOM’s Center for Vaccine Development and Global Health (CVD), is a world-renowned physician and clinical researcher.

“Dr. Kotloff has had a long and distinguished career in pediatric infectious diseases, and she has been instrumental in advancing vaccines and therapies for the most important causes of disease in children throughout the world.,” said UMSOM Dean E. Albert Reece, MD, PhD, MBA, who is also Executive Vice President for Medical Affairs, University of Maryland, and The John Z. and Akiko K. Bowers Distinguished Professor.

Dr. Kotloff has spent her entire 30-year career at the University of Maryland School of Medicine, where she has made fundamental, innovative contributions to research on infectious diseases and childhood and adult vaccines. In developing countries, Dr. Kotloff has conducted vaccine trials as well as large, complex epidemiologic studies to evaluate diarrheal diseases, pneumonia, other vaccine-preventable diseases, and child mortality. In 2001, she helped to establish a field site in Bamako, Mali to study the epidemiology of infectious diseases and their prevention through vaccination. In recognition of this work, she was awarded Chevalier de l’Ordre National du Mali (Knight of the National Order of Mali) in 2005 by the President of Mali.

“Dr. Kotloff is a superb scientist, an international leader in the field of vaccinology and pediatric infectious diseases, and a tireless champion for access to vaccines and children’s health around the globe,” said Kathleen Neuzil, MD, MPH, Professor of Medicine and Pediatrics and Director of the Center for Vaccine Development and Global Health (CVD). “Her research excellence has led to an international reputation, as evidenced by her membership on prestigious national and international committees and her invitations to speak around the globe.”

In addition to her own research, Dr. Kotloff has supported and advanced the careers of dozens of students and post-doctoral trainees here at UMSOM and internationally. Her impact on public health has been multiplied by the physicians and scientists whom she has mentored and trained in these disciplines over the past few decades.

Dr. Kotloff received her BA Degree in Psychology from Washington University in St. Louis. She received her MD Degree from Lewis Katz School of Medicine at Temple University and completed her residency at Children’s Hospital of Pittsburgh, before coming to UMSOM to complete her Fellowship in infectious diseases.

About the University of Maryland School of Medicine

Now in its third century, the University of Maryland School of Medicine was chartered in 1807 as the first public medical school in the United States. It continues today as one of the fastest growing, top-tier biomedical research enterprises in the world -- with 43 academic departments, centers, institutes, and programs; and a faculty of more than 3,000 physicians, scientists, and allied health professionals, including members of the National Academy of Medicine and the National Academy of Sciences, and a distinguished recipient of the Albert E. Lasker Award in Medical Research.  With an operating budget of more than $1 billion, the School of Medicine works closely in partnership with the University of Maryland Medical Center and Medical System to provide research-intensive, academic and clinically based care for more than 1.2 million patients each year. The School has over 2,500 students, residents, and fellows, and more than $530 million in extramural funding, with most of its academic departments highly ranked among all medical schools in the nation in research funding. As one of the seven professional schools that make up the University of Maryland, Baltimore campus, the School of Medicine has a total workforce of nearly 7,000 individuals. The combined School and Medical System (“University of Maryland Medicine”) has an annual budget of nearly $6 billion and an economic impact more than $15 billion on the state and local community. The School of Medicine faculty, which ranks as the 8th highest among public medical schools in research productivity, is an innovator in translational medicine, with 600 active patents and 24 start-up companies. The School works locally, nationally, and globally, with research and treatment facilities in 36 countries around the world. Visit medschool.umaryland.edu.

Contact

Department of Anesthesiology
(410) 328-6120 (phone)
(410) 328-5531 (fax)
newsletter@som.umaryland.edu

Joanne Morrison
Director of Marketing and Public Relations
Center for Vaccine Development and Global Health
University of Maryland School of Medicine
jmorrison@som.umaryland.edu
Office: (410) 706-2884
Mobile: (202) 841-3369

Related stories

    Thursday, December 16, 2021

    Novavax COVID-19 Vaccine Found to be Safe and Effective in Phase 3 Trial Conducted by UM School of Medicine Researchers

    An investigational COVID-19 vaccine made by Novavax was found to be 90 percent effective at preventing COVID-19 illness, according to results from a Phase 3 clinical trial published today in the New England Journal of Medicine. The University of Maryland School of Medicine’s (UMSOM) Center for Vaccine Development and Global Health served as one of the trial sites, and Karen Kotloff, MD, Professor of Pediatrics at UMSOM, served as Co-Chair for the trial protocol.


    Friday, December 18, 2020

    Low-Income Preschoolers Exposed to Nurturing Care Have Higher IQ Scores During Their Teen Years, Landmark Study Finds

    Preschoolers living in impoverished communities who have access to a nurturing home environment have significantly higher intelligence quotient (IQ) scores in adolescence compared to those raised without nurturing care. That is the finding of a new international study conducted by University of Maryland School of Medicine (UMSOM) researchers, which examined data from more than 1,600 children who were followed from birth through their teenage years. Results were published this week in The Lancet Child & Adolescent Health journal.


    Thursday, January 30, 2020

    UMSOM Pediatric Infectious Disease Experts Sound Alarm Over Risk of Outbreaks in U.S. Border Detention Centers

    Over the past year, at least seven children have died from diseases including influenza while being detained by the U.S. Department of Homeland Security’s Customs and Border Protection (CBP) agency. Infectious disease experts at the University of Maryland School of Medicine (UMSOM) called for protections like influenza vaccinations to prevent serious outbreaks.


    Thursday, January 09, 2020

    UM School of Medicine Research Shows Less Severe Cases of Diarrheal Illness can Still Lead to Child Deaths, Even Weeks Following Onset of the Illness

    Diarrheal diseases are a leading cause of death for young children, accounting for nine percent of all deaths worldwide in children under five years of age, with most occurring in children under two years of age. Now, researchers at the University of Maryland School of Medicine (UMSOM) found that even milder cases of diarrheal diseases can lead to death in young children.


    Monday, October 15, 2018

    University of Maryland School of Medicine Scientists Receive Prestigious UMB Founders Week Awards

    Several experts at the UMSOM received prestigious awards commemorating the UMB 2018 Founders Week. Among them, Karen Kotloff, MD, Professor of Pediatrics, was named "Researcher of the Year" for her extensive work in infectious diseases in the U.S. and developing countries. The MARS team – Steven I. Hanish, MD, Visiting Associate Professor of Surgery, Thomas M. Scalea, MD, FACS, FCCM, The Honorable Francis X. Kelly Distinguished Professor in Trauma Surgery, and Deborah Stein, MD, MPH, FACS, FCCM, The R Adams Cowley, MD Professor in Shock and Trauma– were named "Entrepreneurs of the Year" for their liver dialysis device called the Molecular Absorbent Recirculating System (MARS).


    Thursday, April 12, 2018

    Maryland Schools are Doing More to Improve Kids Health, Report Finds

    Schools across Maryland are doing more to encourage their students to eat healthy foods and to be physically active, according to a new report by researchers at the University of Maryland School of Medicine.


    Thursday, January 11, 2018

    Research Shows That Co-Sleeping with Toddlers Can Impact Mother's Mental Health

    For parents of toddlers with sleep problems, co-sleeping may not be a good strategy, according to new research from the University of Maryland School of Medicine (UMSOM) and the University of Maryland School of Nursing (UMSON). Co-sleeping is defined as a parent sleeping in the same room or same bed with their child.


    Monday, September 11, 2017

    Research Identifies Causes and Possible Treatments for Deadly Diseases Affecting Children in Developing Countries

    University of Maryland School of Medicine Researchers Explore How to Prevent Diarrheal Diseases, a Leading Cause of Death in Young Children in Sub-Saharan Africa and South Asia


    Wednesday, June 29, 2016

    UM SOM Researchers Awarded Grant to Use Innovative Alternative to Autopsies to Better Understand Child Mortality

    Kathleen Neuzil, MD, MPH, director of the Center for Vaccine Development (CVD) at the University of Maryland School of Medicine (UM SOM), and UM SOM Dean E. Albert Reece, MD, PhD, MBA, announced today that CVD has been awarded a large grant from the Bill & Melinda Gates Foundation for research that will help determine why so many children under five are dying in the world’s poorest countries. The grant will fund use of an innovative alternative to traditional autopsy known as minimally invasive tissue sampling. The technique, which involves the collection of tissue samples with fine needles, allows researchers to quickly identify the cause of death, and help illuminate ways to save lives and improve the health of children in these vulnerable areas.